Xconomy San Diego

Fate Therapeutics Lands $30,000,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82ae2aa0-df0c-451e-9d26-d03f926c685e&Preview=1
Date
11/16/2009
Company Name
Fate Therapeutics
Mailing Address
10931 North Torrey Pines Road La Jolla, CA 92037
Company Description
The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s reprogramming medicine platform involves developing drugs to reprogram mature adult cells into stem cells which when differentiated can become healthy heart, bone, brain or other tissues.
Website
http://www.fatetherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$30,000,000
Transaction Round
Series B
Proceeds Purposes
The company is looking to complete enrollment in the initial clinical trial of FT-1050 by next spring.
M&A Terms
Venture Investor
OVP Venture Partners
Venture Investor
ARCH Venture Partners
Venture Investor
Polaris Venture Partners
Venture Investor
Venrock